CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Forest Laboratories LLC v. Sigmapharm Laboratories LLC

1:14-cv-01119

Overview

Case Number 1:14-cv-01119
Filing Date 2014-09-03
Status Terminated
Termination Date 2020-09-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Alembic Global Holding S/A Operating Company

Represented By

3 Attorneys Listed

Karen L. Pascale

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Michael W. Glynn

Email: mglynn@kenyon.com

Ksenia Takhistova

UNDELIVERABLE EMAIL 6/28/2019

Alembic Pharmaceuticals Inc. Operating Company

Represented By

3 Attorneys Listed

Karen L. Pascale

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Michael W. Glynn

Email: mglynn@kenyon.com

Ksenia Takhistova

UNDELIVERABLE EMAIL 6/28/2019

Sigmapharm Laboratories LLC Operating Company

Represented By

13 Attorneys Listed

Timothy D. Krieger

Email: tkrieger@simonlawpc.com

John Simon

Email: jsimon@simonlawpc.com

Benjamin R. Askew

Email: baskew@simonlawpc.com

Robert F. Green

Email: rgreen@greengriffith.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Anthony G. Simon

Email: asimon@simonlawpc.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Michael P. Kella

Email: mkella@simonlawpc.com

Marc R. Wezowski

Email: marc.wezowski@huschblackwell.com

John E. Rosenquist

Email: jrosenquist@leydig.com

Anthony R. Friedman

Email: afriedman@simonlawpc.com

Christopher T. Griffith

Email: cgriffith@greengriffith.com

Hikma Pharmaceuticals PLC NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

John K. Hsu

Email: jhsu@schiffhardin.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

West-Ward Pharmaceuticals Corp. Operating Company

Represented By

2 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Alembic Pharmaceuticals Ltd. Operating Company

Represented By

9 Attorneys Listed

Steven J. Lee Ph.D.

UNDELIVERABLE EMAIL 5/18/20

Karen L. Pascale

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Michael W. Glynn

Email: mglynn@kenyon.com

Karen Shen

UNDELIVERABLE EMAIL 7/7/2017

Michael K. Levy

UNDELIVERABLE EMAIL 9/22/2017

Paul M. Richter

Email: prichter@devlinlawfirm.com

Nitya Anand

Email: nanand@mwe.com

Nathan Newbold

UNDELIVERABLE EMAIL 5/23/16

Ksenia Takhistova

UNDELIVERABLE EMAIL 6/28/2019

Plaintiff

Allergan USA, Inc. Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Allergan Sales, LLC Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Allergan Pharmaceuticals International Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Hikma Pharmaceuticals LLC Operating Company

Represented By

5 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

Joel M. Wallace

Email: joel.wallace@afslaw.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Imron T. Aly

Email: ialy@schiffhardin.com

Helen H. Ji

Email: jelen.ji@afslaw.com

Forest Laboratories LLC Operating Company

Represented By

9 Attorneys Listed

Aaron G. Clay

Email: aaron.clay@finnegan.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Charles E. Lipsey

Email: charles.lipsey@finnegan.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Seth R. Ogden

Email: sro@iplawgroup.com

Sanya Sukduang

Email: ssukduang@cooley.com

Jonathan R. Davies

Email: jdavies@cooley.com

Howard W. Levine

Email: howard.levine@dechert.com

Breckenridge Pharmaceutical Inc. Operating Company

Represented By

6 Attorneys Listed

Beth D. Jacob

UNDELIVERABLE EMAIL 1/25/2018

Sara E. Bussiere

UNDELIVERABLE EMAIL 5/28/2021

Tel: +1 (302) 655-5000

Vanessa Ribeiro Tiradentes

Gould & Ratner LLP

Tel: +1 (312) 899-1628

222 N. LaSalle Street, Suite 800

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Richard D. Kirk

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

ADDRESS EXPIRED / UNKNOWN, (302) 655-5000

Clifford E. Katz

Email: ckatz@kelleydrye.com

Forest Laboratories Holdings Ltd. NPE (Patent Assertion Entity)

Represented By

3 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Amneal Pharmaceuticals Co. India Pvt. Ltd. Operating Company

Represented By

5 Attorneys Listed

Jennifer M. Rutter

Gibbons P.C.

Tel: +1 (302) 518-6320
Fax: +1 (302) 397-2329

300 Delaware Avenue, Ste 1015

Aiyda Ghahramani

Email: aghahramani@sughrue.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

1000 West Street, Suite 1501, Wilmington, DE 19801

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Robert Karl Beste , III

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Corporate Plaza, 800 Delaware Ave.

Amneal Pharmaceuticals LLC Operating Company

Represented By

8 Attorneys Listed

Jennifer M. Rutter

Gibbons P.C.

Tel: +1 (302) 518-6320
Fax: +1 (302) 397-2329

300 Delaware Avenue, Ste 1015

Michael R. Dzwonczyk

Email: mdzwonczyk@sughrue.com

Azy S. Kokabi

UNDELIVERABLE EMAIL 4/6/2018

Alton L. Hare , III

Email: alton.hare@pillsburylaw.com

Aiyda Ghahramani

Email: aghahramani@sughrue.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

1000 West Street, Suite 1501, Wilmington, DE 19801

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Robert Karl Beste , III

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Corporate Plaza, 800 Delaware Ave.

Amneal Pharmaceuticals of New York LLC Operating Company

Represented By

5 Attorneys Listed

Jennifer M. Rutter

Gibbons P.C.

Tel: +1 (302) 518-6320
Fax: +1 (302) 397-2329

300 Delaware Avenue, Ste 1015

Aiyda Ghahramani

Email: aghahramani@sughrue.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

1000 West Street, Suite 1501, Wilmington, DE 19801

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Robert Karl Beste , III

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Corporate Plaza, 800 Delaware Ave.

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇪🇺 Europe 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2015-05-28
1:15-cv-00430

Forest Laboratories LLC v. Amneal Pharmaceuticals LLC

U.S. Family Sibling (["US5763476"])
Status: DED
U.S. District Court 2015-02-13
1:15-cv-00158

Forest Laboratories LLC v. Alembic Pharmaceuticals Ltd.

U.S. Family Sibling (["US5763476"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5763476
Sublingual or buccal pharmaceutical composition
Filed: 1995-03-01
Issued: 1998-06-09
Expired (Term Ended) +1927d PTA
Expires: 2020-06-09
US7741358
Crystal form of asenapine maleate
Filed: 2006-04-06
Issued: 2010-06-22
Expired (Term Ended)
Expires: 2026-04-06
US8022228
Crystal form of asenapine maleate
Filed: 2007-11-13
Issued: 2011-09-20
Active (1.3 yrs remaining) +127d PTA
Expires: 2028-03-19

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1927 days) / Cellect Scrutiny — Over 1927 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

18

Dispositive

0

Granted

0

Denied

0

Pending / Review

17

Motions by Category

Claim Construction / Markman Filing 18

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION ANSWERING BRIEF re 71 Claim Construction Opening Brief, 53 Claim Construction Opening Brief filed by Forest Laboratories Holdings Ltd., Fores...
Entry #85 • 2015-11-05 Document →
Claim Construction / Markman Filing Pending / Under Review
DECLARATION of Dr. Lisbeth Illum re 85 Claim Construction Answering Brief by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Attachments: # 1 Exhib...
Entry #86 • 2015-11-05 Document →
Claim Construction / Markman Filing Pending / Under Review
DECLARATION of Joel Bernstein, Ph.D. re 85 Claim Construction Answering Brief by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Attachments: # 1 E...
Entry #87 • 2015-11-05 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION ANSWERING BRIEF re 58 Claim Construction Opening Brief,, filed by Alembic Global Holding SA, Alembic Pharmaceuticals Inc., Alembic Pharmaceut...
Entry #88 • 2015-11-05 Document →
Claim Construction / Markman Filing Pending / Under Review
Supplemental CLAIM CONSTRUCTION OPENING BRIEF filed by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Noreika, Maryellen) (Main Document 71 replac...
Entry #71 • 2015-10-06 Document →
Claim Construction / Markman Filing Pending / Under Review
Supplemental DECLARATION of Dr. Joseph McEvoy, M.D. re 71 Claim Construction Opening Brief by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Attac...
Entry #72 • 2015-10-06 Document →

Docket Entries

(107 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Sigmapharm Laboratories LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1580970.) - filed by Forest Laboratories LLC, Forest Laboratories Holdings Ltd.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(rwc) (Entered: 09/04/2014)

Entry #1 • 2014-09-03
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Sigmapharm Laboratories LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1580970.) - filed by Forest Laboratories LLC, Forest Laboratories Holdings Ltd.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(rwc) (Entered: 09/04/2014)

Entry #1 • 2014-09-03
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Sigmapharm Laboratories LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1580970.) - filed by Forest Laboratories LLC, Forest Laboratories Holdings Ltd.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(rwc) (Entered: 09/04/2014)

Entry #1 • 2014-09-03
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 09/04/2014)

Entry #2 • 2014-09-03
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/8/14. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 2/9/2017. (rwc) (Main Document 3 replaced on 9/4/2014) (rwc). (Entered: 09/04/2014)

Entry #3 • 2014-09-03
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc